Engineering bone: challenges and obstacles

被引:242
作者
Logeart-Avramoglou, D [1 ]
Anagnostou, F [1 ]
Bizios, R [1 ]
Petite, H [1 ]
机构
[1] Univ Paris 07, Fac Med Lariboisiere St Louis, CNRS, SPI,UMR 7052,Lab Rech Orthoped, F-75010 Paris, France
关键词
tissue engineering; bone; biomaterials; stem cells;
D O I
10.1111/j.1582-4934.2005.tb00338.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Repair of large bone defects is still a challenge for the orthopaedic, reconstructive and maxillo-facial surgeon. Availability of pluripotent stem cells from either autologous or allogenic sources and the potential of inducing the osteogenic phenotype is motivating exploration and development of custom-tailored materials known as "bioengineered bone constructs". In such cases, the clinical scenario involves either expansion of stem cells in monolayer and loading them into a porous scaffold prior to surgery or direct cell expansion within the scaffold, and implanting this novel construct back into the donor patient. In this review, we delineate, from an engineering perspective, the progress that has been made to date and the challenges remaining in successfully translating this promising (but not yet definitively established) approach from bench to the bedsite.
引用
收藏
页码:72 / 84
页数:13
相关论文
共 75 条
[31]  
2-P
[32]  
Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO
[33]  
2-I
[34]   Mesenchymal stem cells: Paradoxes of passaging [J].
Javazon, EH ;
Beggs, KJ ;
Flake, AW .
EXPERIMENTAL HEMATOLOGY, 2004, 32 (05) :414-425
[35]   Accelerated and improved osteointegration of implants biocoated with bone morphogenetic protein 2 (BMP-2) [J].
Jennissen, HP .
REPARATIVE MEDICINE: GROWING TISSUES AND ORGANS, 2002, 961 :139-142
[36]  
Jin QM, 2000, J BIOMED MATER RES, V51, P491, DOI 10.1002/1097-4636(20000905)51:3<491::AID-JBM25>3.0.CO
[37]  
2-1
[38]   Culture-expanded, bone marrow-derived mesenchymal stem cells can regenerate a critical-sized segmental bone defect [J].
Kadiyala, S ;
Jaiswal, N ;
Bruder, SP .
TISSUE ENGINEERING, 1997, 3 (02) :173-185
[39]  
KIEVITS F, 1988, J IMMUNOL, V140, P4253
[40]   Potential applications and delivery strategies for bone morphogenetic proteins [J].
Kirker-Head, CA .
ADVANCED DRUG DELIVERY REVIEWS, 2000, 43 (01) :65-92